The complex rich microenvironment and the presence of multiple redundant oncogenic survival pathways at the primary tumor site in vivo may reduce the requirement for and hence, mask the effect of Bit1 on Erk-mediated signaling during tumor growth. The gene discussed is PTRH2; the disease is neoplasm.